Literature DB >> 16952042

Intratumoral heterogeneity of MIB-1 labelling index in gastric gastrointestinal stromal tumor (GIST).

Hiroshi Yasui1, Eiichi Konishi, Koji Urasaki, Satoru Yasukawa, Akio Yanagisawa.   

Abstract

BACKGROUND: The MIB-1 labelling index (LI) is used as a prognostic indicator for gastrointestinal stromal tumors (GISTs). However, whether a biopsy-based LI represents the entire tumor is uncertain, because the LI is not always homogeneous. In this study, we examined the extent and characteristics of LI heterogeneity in gastric GISTs.
METHODS: We analyzed ten c-kit-positive gastric GISTs with diameters exceeding 3 cm, of which six were multilobular and four were unilobular. For MIB-1-immunostained sections, continuous digital images were obtained through the maximum diameter of the lobules. We obtained LIs for images by carrying out computer-assisted image analysis, and calculated the means and standard deviations (SDs) of the LIs for the lobules. For each lobule, intralobular heterogeneity was evaluated on the basis of the SD. For multilobular tumors, interlobular heterogeneity was assessed on the basis of the mean LI difference between lobules.
RESULTS: The SDs, which ranged from 0.8% to 9.8%, indicated intralobular heterogeneity. Moreover, considerable interlobular heterogeneity was noted in five (83%) of the six multilobular GISTs, in which the maximum interlobular mean LI difference ranged from 9.6% to 27.2%. Notably, although the high maximum mean LI (14.1%-32.3%) showed that these five GISTs were high-grade tumors, they also contained at least one lobule showing a low-grade mean LI value (2.7%-5.1%).
CONCLUSION: Gastric GISTs often show intralobular or interlobular MIB-1 LI heterogeneity. In multilobular GISTs, multiple biopsy samples may be required for the accurate evaluation of tumor grade.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16952042     DOI: 10.1007/s10120-006-0386-3

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN: 1436-3291            Impact factor:   7.370


  16 in total

Review 1.  Ki67 protein: the immaculate deception?

Authors:  D C Brown; K C Gatter
Journal:  Histopathology       Date:  2002-01       Impact factor: 5.087

2.  Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up.

Authors:  Markku Miettinen; Leslie H Sobin; Jerzy Lasota
Journal:  Am J Surg Pathol       Date:  2005-01       Impact factor: 6.394

3.  Expression of c-kit (CD117) and Ki67 provides information about the possible cell of origin and clinical course of gastrointestinal stromal tumours.

Authors:  T Seidal; H Edvardsson
Journal:  Histopathology       Date:  1999-05       Impact factor: 5.087

4.  Prognostic assessment of gastrointestinal stromal tumor.

Authors:  Hui Yan; Pierre Marchettini; Yair I Z Acherman; Sue Ann Gething; Erwin Brun; Paul H Sugarbaker
Journal:  Am J Clin Oncol       Date:  2003-06       Impact factor: 2.339

5.  Heterogeneity in proliferation markers in colorectal cancer.

Authors:  U Kressner; G Lindmark; B Gerdin; L Pahlman; B Glimelius
Journal:  Anticancer Res       Date:  1995 Nov-Dec       Impact factor: 2.480

6.  Quantitative immunohistochemical evaluation of MIB-1 labeling index in adult soft-tissue sarcomas by computer-assisted image analysis.

Authors:  Tadashi Hasegawa; Seiichiro Yamamoto; Yoshihiro Matsuno
Journal:  Pathol Int       Date:  2002-07       Impact factor: 2.534

Review 7.  Diagnosis of gastrointestinal stromal tumors: A consensus approach.

Authors:  Christopher D M Fletcher; Jules J Berman; Christopher Corless; Fred Gorstein; Jerzy Lasota; B Jack Longley; Markku Miettinen; Timothy J O'Leary; Helen Remotti; Brian P Rubin; Barry Shmookler; Leslie H Sobin; Sharon W Weiss
Journal:  Hum Pathol       Date:  2002-05       Impact factor: 3.466

Review 8.  Biology of gastrointestinal stromal tumors.

Authors:  Christopher L Corless; Jonathan A Fletcher; Michael C Heinrich
Journal:  J Clin Oncol       Date:  2004-09-15       Impact factor: 44.544

9.  Gastrointestinal stromal tumor: consistent CD117 immunostaining for diagnosis, and prognostic classification based on tumor size and MIB-1 grade.

Authors:  Tadashi Hasegawa; Yoshihiro Matsuno; Tadakazu Shimoda; Setsuo Hirohashi
Journal:  Hum Pathol       Date:  2002-06       Impact factor: 3.466

10.  Heterogeneity of proliferative activity in nodule-in-nodule lesions of small hepatocellular carcinoma.

Authors:  Y Matsuno; S Hirohashi; S Furuya; M Sakamoto; K Mukai; Y Shimosato
Journal:  Jpn J Cancer Res       Date:  1990-11
View more
  4 in total

1.  Empirical chemosensitivity testing in a spheroid model of ovarian cancer using a microfluidics-based multiplex platform.

Authors:  Tamal Das; Liliane Meunier; Laurent Barbe; Diane Provencher; Olivier Guenat; Thomas Gervais; Anne-Marie Mes-Masson
Journal:  Biomicrofluidics       Date:  2013-01-10       Impact factor: 2.800

2.  Monitoring the HER2 copy number status in circulating tumor DNA by droplet digital PCR in patients with gastric cancer.

Authors:  Katsutoshi Shoda; Daisuke Ichikawa; Yuji Fujita; Kiyoshi Masuda; Hidekazu Hiramoto; Junichi Hamada; Tomohiro Arita; Hirotaka Konishi; Shuhei Komatsu; Atsushi Shiozaki; Naoki Kakihara; Kazuma Okamoto; Hiroki Taniguchi; Issei Imoto; Eigo Otsuji
Journal:  Gastric Cancer       Date:  2016-02-13       Impact factor: 7.370

3.  Phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumours of the stomach.

Authors:  Yukinori Kurokawa; Han-Kwang Yang; Haruhiko Cho; Min-Hee Ryu; Toru Masuzawa; Sook Ryun Park; Sohei Matsumoto; Hyuk-Joon Lee; Hiroshi Honda; Oh Kyoung Kwon; Takashi Ishikawa; Kyung Hee Lee; Kazuhito Nabeshima; Seong-Ho Kong; Toshio Shimokawa; Jeong-Hwan Yook; Yuichiro Doki; Seock-Ah Im; Seiichi Hirota; Seokyung Hahn; Toshirou Nishida; Yoon-Koo Kang
Journal:  Br J Cancer       Date:  2017-05-23       Impact factor: 7.640

4.  Endoscopic Ultrasonography-guided Fine-needle Aspiration Cytology Combined with a Cell-block Method for Gastrointestinal Subepithelial Lesions.

Authors:  Takeshi Shimizu; Shinsuke Koshita; Tetsuya Ohira; Yoshihiro Harada; Yoshihide Kanno; Takahisa Ogawa; Taku Yamagata; Hiroaki Kusunose; Toshitaka Sakai; Takashi Tsuchiya; Masaya Oikawa; Yutaka Noda; Takashi Sawai; Kei Ito
Journal:  Intern Med       Date:  2021-09-11       Impact factor: 1.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.